These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9621483)
1. Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment. Vici P; Ferraironi A; Di Lauro L; Carpano S; Conti F; Belli F; Paoletti G; Maini CL; Lopez M Clin Ter; 1998; 149(921):15-20. PubMed ID: 9621483 [TBL] [Abstract][Full Text] [Related]
2. Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas. Lopez M; Vici P; Di Lauro K; Conti F; Paoletti G; Ferraironi A; Sciuto R; Giannarelli D; Maini CL J Clin Oncol; 1998 Jan; 16(1):86-92. PubMed ID: 9440727 [TBL] [Abstract][Full Text] [Related]
3. Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer. Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina RC; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte PF; Rosso R J Clin Oncol; 1996 Dec; 14(12):3112-20. PubMed ID: 8955656 [TBL] [Abstract][Full Text] [Related]
4. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group. Seymour L; Bramwell V; Moran LA Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762 [TBL] [Abstract][Full Text] [Related]
5. European trials with dexrazoxane in amelioration of doxorubicin and epirubicin-induced cardiotoxicity. Lopez M; Vici P Semin Oncol; 1998 Aug; 25(4 Suppl 10):55-60. PubMed ID: 9768825 [TBL] [Abstract][Full Text] [Related]
6. [Protective effect of dexrazoxane on cardiotoxicity in breast cancer patients who received anthracycline-containing chemotherapy]. Wang P; Zhang S; Zhang XB; Li WJ; Hao XM; Zhang J Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):135-9. PubMed ID: 23714670 [TBL] [Abstract][Full Text] [Related]
7. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. Jain KK; Casper ES; Geller NL; Hakes TB; Kaufman RJ; Currie V; Schwartz W; Cassidy C; Petroni GR; Young CW J Clin Oncol; 1985 Jun; 3(6):818-26. PubMed ID: 3859587 [TBL] [Abstract][Full Text] [Related]
8. Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients. Michelotti A; Venturini M; Tibaldi C; Bengala C; Gallo L; Carnino F; Del Mastro L; Lionetto R; Montanaro E; Rosso R; Conte P Breast Cancer Res Treat; 2000 Jan; 59(2):133-9. PubMed ID: 10817348 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience. Testore F; Milanese S; Ceste M; de Conciliis E; Parello G; Lanfranco C; Manfredi R; Ferrero G; Simoni C; Miglietta L; Ferro S; Giaretto L; Bosso G Am J Cardiovasc Drugs; 2008; 8(4):257-63. PubMed ID: 18690759 [TBL] [Abstract][Full Text] [Related]
11. Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy. Wiseman LR; Spencer CM Drugs; 1998 Sep; 56(3):385-403. PubMed ID: 9777314 [TBL] [Abstract][Full Text] [Related]
12. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer. Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy. Basser RL; Sobol MM; Duggan G; Cebon J; Rosenthal MA; Mihaly G; Green MD J Clin Oncol; 1994 Aug; 12(8):1659-66. PubMed ID: 8040678 [TBL] [Abstract][Full Text] [Related]
14. Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients. Galetta F; Franzoni F; Cervetti G; Cecconi N; Carpi A; Petrini M; Santoro G Biomed Pharmacother; 2005 Dec; 59(10):541-4. PubMed ID: 16325366 [TBL] [Abstract][Full Text] [Related]
15. Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer. Basser RL; Abraham R; To LB; Fox RM; Green MD Ann Oncol; 1999 Jan; 10(1):53-8. PubMed ID: 10076722 [TBL] [Abstract][Full Text] [Related]
16. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits. Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762 [TBL] [Abstract][Full Text] [Related]
17. Adult multicenter trials using dexrazoxane to protect against cardiac toxicity. Swain SM Semin Oncol; 1998 Aug; 25(4 Suppl 10):43-7. PubMed ID: 9768823 [TBL] [Abstract][Full Text] [Related]
18. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656 [TBL] [Abstract][Full Text] [Related]
19. Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety. Catimel G; Spielmann M; Dieras V; Kayitalire L; Pouillart P; Guastalla JP; Soler-Michel P; Graffand N; Garet F; Dumortier A; Pellae-Cosset B; Chazard M Semin Oncol; 1996 Feb; 23(1 Suppl 1):24-7. PubMed ID: 8629032 [TBL] [Abstract][Full Text] [Related]
20. Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer. Nielsen D; Jensen JB; Dombernowsky P; Munck O; Fogh J; Brynjolf I; Havsteen H; Hansen M J Clin Oncol; 1990 Nov; 8(11):1806-10. PubMed ID: 2230869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]